GLPG (glpg.com) Bozor qiymatining balans qiymatiga nisbati

Galapagos N.V. (GLPG) kompaniyasining rasmiy ramzlari

Galapagos NV (GLPG) molekulalar ishlab chiqarish va tadqiqotlar uchun tashqi pudratchilarga tayanadi. Ushbu grafik aktivning narxlar dinamikasini aks ettiradi, bunda asosiy ko'rsatkich 0.48 hisoblanadi. Kompaniya hozirda yangi dori vositalari tasdiqlanishini kutayotgan bir paytda, patent muddatining tugashi tufayli mijozlarning chiqib ketish muammolariga duch kelmoqda. Shu bilan birga, Galapagos NV (GLPG) CAR-T terapiyalarini bevosita tibbiyot markazlarida ishlab chiqarish tarmog'ini yaratish orqali decentralizatsiyalashgan yondashuvni joriy qilmoqda.

GLPG Galapagos Corp: Balans qiymatiga nisbatan bozor qiymati 04.07.2022 - 08.05.2026 oraligʻida

Galapagos N.V. (GLPG) moliyaviy va bozor koʻrsatkichlari kesimi

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi Galapagos NV|GLPG - Tahlilchilar maqsadlari diapazoni
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Galapagos Genomics|GLPG - Biznesning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Galapagos|GLPG - Kompaniyaning buxgalteriya qiymati|Bozor kapitallashuvining balans qiymatiga nisbati glpg.com|GLPG - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Galapagos NV|GLPG - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Galapagos Genomics|GLPG - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Galapagos Genomics|GLPG - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Galapagos
Kompaniyaning dastlabki tahlili:Galapagos NV - GLPG
Galapagos Genomics original mahsuloti

Oldingi tranzaksiyalardan hosil bo'lgan barqaror likvidlik rezervi Galapagos NV kompaniyasiga CAR-T terapiyasiga e'tibor qaratish imkonini beradi, bu esa bozor kapitalizatsiyasining kitob qiymatidan qanchalik yuqori ekanligiga bevosita ta'sir qiladi. Ushbu ko'rsatkich biznesning bozor qiymatini uning sof aktivlari bilan solishtiradi, bu esa investorlarga real vaqt rejimidagi baholash orqali kompaniyaning haqiqiy kapitalga nisbatan haddan tashqari yuqori yoki past baholanganlik darajasini aniqlash imkonini beradi.

Asosiy raqobatchilar

Bozor kapitallashuvining balans qiymatiga nisbati HLN (Haleon plc)|KVUE (kenvue.com) - Bozor qiymatining xususiy kapitalga nisbati|Bozor qiymatining balans qiymatiga nisbati Verona Pharma VRNA|Sof aktivlarga nisbatan bozor kapitallashuvi Jyong Biotech Limited|Ligand Pharma (LGND) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Amneal Corp (AMRX)|Bozor kapitallashuvining balans qiymatiga nisbati PRGO (Perrigo Company plc)|alvotech.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Liquidia (LQDA)|ANIP: Balans qiymatiga nisbatan bozor qiymati|MNKD (MannKind Corp.) - Bozor qiymatining balans qiymatiga nisbati|Amphastar Corp (AMPH) - Kapitallashuvning sof aktivlarga nisbati|PCRX (Pacira BioSciences) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati ars-pharma.com (SPRY)|Theravance Biopharma, Inc. (TBPH) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati AQST (Aquestive Therapeutics Inc)|SCPH: Bozor qiymatining balans qiymatiga nisbati|TECX - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Tonix Pharmaceuticals TNXP|SXTC - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati eupraxiapharma.com EPRX|BioHarvest Sciences, Inc. (BHST) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati EXOZ (Invizyne Technologies, Inc.)|Bozor qiymatining balans qiymatiga koeffitsiyenti ORMP|Entera Bio Ltd. (ENTX) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati ipatherapeutics.com (HYFT)|ABVC (ABVC BioPharma, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining xususiy kapitalga nisbati Cumberland Pharmaceuticals Inc CPIX|Quantum BioPharma Limited - Bozor kapitallashuvining balans qiymatiga nisbati|FGEN: Bozor kapitallashuvining balans qiymatiga nisbati|Telomir Pharmaceuticals (TELO) - Bozor qiymatining balans qiymatiga nisbati|Rani Therapeutics Holdings, Inc. (RANI) - Bozor qiymatining balans qiymatiga nisbati|SNYR (Synergy CHC Corp.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati RLYB|LEXX - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi Pulmatrix Corporation (PULM)|Bozor kapitallashuvining balans qiymatiga nisbati PTHL (Pheton Holdings)|Bozor kapitallashuvining balans qiymatiga nisbati Aptorum Group Ltd APM|Bozor kapitallashuvining balans qiymatiga nisbati LYRA|IBO: Bozor qiymatining xususiy kapitalga nisbati|Bozor qiymatining balans qiymatiga nisbati TNFA|YCBD (cbdMD) - Bozor qiymatining balans qiymatiga koeffitsiyenti|PRFX: Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Auris Medical (CYTO)|Lipella Pharmaceuticals, Inc. (LIPO) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati OPTN (OptiNose Inc)|PIRS - Bozor qiymatining balans qiymatiga nisbati|PROC - Kapitallashuvning balans qiymatiga nisbati|PTPI - Kapitallashuvning sof aktivlarga nisbati|QLI - Bozor qiymatining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati SLRN (ACELYRIN)|TFFP (TFF Pharmaceuticals Inc.) - Bozor qiymatining xususiy kapitalga nisbati